Skip to main content
TipRanks
Go Ultimate75% OFF

Relmada Therapeutics (RLMD) Q4 2020 Earnings Report

445 Followers

RLMD Q4 2020 EPS Results

Actual EPS
-$1.28
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
―

RLMD Q4 2020 Revenue Results

Actual Revenue
$0
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q4 2020
Date
03/23/2021
Time
After Close
Conference Call
Tuesday, March 23, 2021
RLMD Upcoming Earnings

Relmada Therapeutics's next earnings date is estimated for March 23, 2027, based on past reporting schedules.

Q4 2020 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2020 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2020 Earnings Call Summary

No earnings call summary is available for this earnings event.

RLMD Earnings History

RLMD earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 23, 20272026 (Q4)-0.13--0.27――
Nov 12, 20262026 (Q3)-0.14-0.12-0.360.00% (+0.18)
Aug 06, 20262026 (Q2)-0.20-0.11-0.363.33% (+0.19)
May 12, 20262026 (Q1)-0.20-0.22-0.5862.07% (+0.36)
Mar 19, 20262025 (Q4)-0.15-0.27-0.6256.45% (+0.35)
Nov 13, 20252025 (Q3)-0.42-0.30-0.7258.33% (+0.42)
Aug 07, 20252025 (Q2)-0.46-0.30-0.5949.15% (+0.29)
May 12, 20252025 (Q1)-0.48-0.58-0.7219.44% (+0.14)
Mar 27, 20252024 (Q4)-0.67-0.62-0.8426.19% (+0.22)
Nov 07, 20242024 (Q3)-0.68-0.72-0.731.37% (+0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed